Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Translational Development Acquisition (TDAC) Payables (2023 - 2026)

Translational Development Acquisition's Payables history spans 4 years, with the latest figure at $724323.0 for Q1 2026.

  • On a quarterly basis, Payables rose 221.24% to $724323.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $724323.0, a 221.24% increase, with the full-year FY2025 number at $362311.0, up 2138.01% from a year prior.
  • Payables came in at $724323.0 for Q1 2026, up from $362311.0 in the prior quarter.
  • The five-year high for Payables was $724323.0 in Q1 2026, with the low at $16189.0 in Q4 2024.
  • Historically, Payables has averaged $301579.3 across 4 years, with a median of $271083.0 in 2025.
  • Biggest five-year swings in Payables: tumbled 95.36% in 2024 and later surged 2138.01% in 2025.
  • Year by year, Payables stood at $348752.0 in 2023, then plummeted by 95.36% to $16189.0 in 2024, then skyrocketed by 2138.01% to $362311.0 in 2025, then soared by 99.92% to $724323.0 in 2026.
  • Business Quant data shows Payables for TDAC at $724323.0 in Q1 2026, $362311.0 in Q4 2025, and $271083.0 in Q3 2025.